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Abstract—Several cinchona based squaramide catalysts were applied in asymmetric Michael addition of α-
nitroethylphosphonates to acrylic acid aryl esters, resulting in high yield and enantioselectivity. The absolute 
configuration of one of the quaternary α-nitrophosphonate adducts was deduced from its experimental and 
calculated CD spectra. The adducts were reduced to their cyclic aminophosphonates by catalytic hydrogenation. 
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1. Introduction 
 
Racemic and non-racemic α-aminophosphonic acid derivatives are considered to be structural and functional 
surrogates of the proteinogenic and non-proteinogenic amino acids.1 Since their mode of action involves the 
inhibition of enzymes of different type, they were tested for a variety of biological effects ranging from medicine 
to agrochemistry.2 This property was exploited in the development of new antibacterial,3 antihypertensive4 and 
anti-HIV agents5 or herbicides.6 Among the naturally occurring aminophosphonates K-26, a tripeptide 
phosphonic acid, shows ACE inhibitory activity.7 Moreover, due to their metal complexing character, 
aminobisphosphonic acid derivatives have become important in the treatment of osteoporosis and bone 
metastases.8 
Since biological activity is strongly influenced by the configuration of carbon atom adjacent to phosphorus, 
various synthetic methods providing non-racemic α-aminophosphonates were developed in the last decade and 
have recently been reviewed.9 Among them, numerous enantioselective synthetic methods based on chiral 
auxiliaries were reported.10In the last few years interest was focused on catalytic stereoselective strategies 
involving both P-C11 and C-C12 coupling approaches. 
As a part of our research program, aiming at the enantioselective synthesis of aminophosphonates, we have 
recently described stereoselective Michael additions of N-protected aminomethyl phosphonates to acrylic acid 
derivatives catalyzed by TADDOL.12b and sugar12d  and BINOL12e based crown ethers. The stereoselective 
construction of a quaternary carbon stereocenter generated using a chiral catalyst, i.e. the synthesis of -
substituted -aminophosphonates, appeared to be a logical extension of our research. Quaternary -
aminophosphonates could be useful for biomimetic research, because incorporation them into peptides may 
lend them increased rigidity and resistance to proteases. Although numerous -substituted -
aminophosphonates were synthesised as racemates,13 only a few enantioselective methods have been applied 
to this class of compounds.14 
Optically active organocatalysts have acquired ever more importance in the enantioselective synthesis of chiral 
compounds.15 Among them cinchona alkaloid derivatives proved to be excellent catalysts in enantioselective 
Michael additions.16 
Herein, we report a new organocatalytic, enantioselective Michael addition of α-nitroethylphosphonates (1) to 
acrylic acid esters (2) (Scheme 1). The Michael adducts (3) can serve as direct precursors of optically active α-
substituted α-aminophosphonic acids (5) (Scheme 3). 
 
2. Results and discussion 
 
2.1 Synthesis of α-nitrophosphonates 
 
Our earlier attempts to promote addition of diethyl α-nitroethylphosphonate17 (1a) to alkyl acrylates (2, R: ethyl 
or t-butyl) and benzyl acrylate (2, R: benzyl) failed in the presence of any of the catalysts 4a-n. Using aryl 
acrylates18 (2a, R: phenyl), however, the Michael reaction proceeded smoothly providing the expected 
substituted α-nitroethylphosphonate (3a, R: phenyl). 
First both catalytic activity and selectivity in the Michael addition of a cyclohexanediamine based thiourea 
catalyst (4a), cinchonine (4b), quinidine (4c), cinchonidine (4d), quinine (4e), two bifunctional thiourea 
derivatives of cinchona alkaloids (4f and 4g) and seven squaramide derivatives of cinchona alkaloids (4h-n) were 
tested (Scheme 1, Figure 1). Note, that while the cinchona based catalysts 4b-j were already often used in 
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enantioselective syntheses, the benzyl squaramide derivative (4k) was only synthesised recently19, and applied 
in a stereoselective C-C coupling reaction. The other benzyl squaramide derivatives (4l-n) are new. The reactions 
were performed at room temperature in toluene using 10 mol% of the catalyst. As it can be gleaned from Table 
1, all of the catalysts, except 4m provided the quaternary nitrophosphonate (3a) in excellent yield. While 
selectivity of the catalysts varied from low (4a, entry 1) to medium (4b-e, entries 2-5), the enantiomeric excess 
(ee) values were more promising with catalysts bearing a thiourea moiety (4f and 4g, entries 6, 7). 
Among the squaramide type catalysts (4h-n, entries 8-14) those in which the aromatic ring is next to the acidic 
NH showed reduced selectivity (4h-j, entries 8-10), while benzyl substituted squaramide derivatives provided 
the highest ee values (4k, 4m and 4n, entries 11, 13 and 14). Although the ethyl chain on the bridged cycle (4m, 
entry 13) enhanced enantioselectivity the reaction slowed down probably due to poor solubility of the catalyst. 
The squaramide derivative possessing disubstituted benzyl group (4l, entry 12) showed one of the lowest 
selectivities among catalysts tested. Finally in the optimization experiments 4k proved to be the most effective 
catalyst. 
In order to optimize conditions of the Michael addition the effect of solvent, temperature and catalyst loading 
were examined using the best catalyst (4k). According to data in Table 2, toluene proved to be the best solvent 
both in terms of yield and stereoselectivity (entry 1). In more polar solvents, such as CH2Cl2, CH3CN, THF, dioxane 
and anisole, yields were high, but selectivity decreased to  medium values (entries 2-6). Relatively low 
enantioselectivity in xylene may be attributed to  poor solubility of the catalyst (entry 7). Lowering the 
temperature to 0 and -30°C the reaction slowed down and also selectivity decreased (entries 8 and 9). Catalyst 
loading could be decreased from 10 to 5 mol% without loss of yield and selectivity (entry 10), while there was a 
slight drop of chiral induction was found when only 2 mol% of the catalyst was used (entry 11). Using butyl and 
isopropyl phosphonate esters did not affect reaction rate, but decreased enantioselectivity (entries 1-3). 
Next, Michael reaction of ethyl α-nitroethylphosphonate (1a) with a range of aryl acrylates (2a-t) was examined. 
It can be seen from Table 3 that the reactions were quantitative with medium to excellent enantioselectivity 
with all aryl acrylates. It turned out, that acrylates having an electron-withdrawing group in any position in the 
aromatic ring afforded the adducts 3 with lower ee (entries 4-7 and 20) while aryl acrylates bearing electron-
donating groups all gave good to excellent enantioselectivities (entries 8-13 and 15-19). No significant 
differences in ee values were, however, observed between the alkyl (entries 8-13) and the stronger electron-
donating methoxy substituents (entries 15-19) whereas the position of the substituents seemed to have an 
impact on the selectivity. Thus. the bulky aryl esters furnished the adducts with best enantioselectivities, 
although with slightly lower rates (entries 13, 14 and 19). The highest ee values were observed for the 2,6-
dimethoxyphenyl (3t, 96%, entry 19), the 2,6-dimethylphenyl (3k, 90%, entry 11) and the 2-methyl-4-tert-
butylphenyl (3m, 89%, entry 13) derivatives. 
 
2.2 Synthesis of α-aminophophonates 
 
Since the most important synthetic utility of quaternary α-nitrophosphonate adducts (3) is the straightforwad 
access to quaternary α-aminophosphonates, catalytic hydrogenation of three representative examples (3a, 3r 
and 3t) was performed to their cyclic α-aminophosphonates (Scheme 3). All hydrogenation reactions were 
carried out over a 10% Pd/C catalyst (Selcat Q20), in ethanol, under pressure. After 4 h reaction time, the 
conversion of 3 was complete at 10 bar and 30 °C. It was found that a mixture of two cyclic phosphonates, the 
expected lactame (5) and a cyclic imine (6) were formed in all cases. The ratio of 5 and 6 depended on both the 
pressure and the bulkiness of R group of 3. At higher pressure (30 bar) the formation of 5 was favoured. 
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Furthermore, it was observed that the ratio of the expected 5 and the by-product 6 was the highest (6:1) in case 
of 3a (R: phenyl) at 10 bar, while for 3r (R: 2-MeOPh) it was 4.5:1, and for 3t (R: 2,6-diMeOPh) was only 1:1. 
Increasing the pressure to 30 bar the latter ratio increased to 1.6:1. These significant differences, presumably, 
were due to the very stable and good leaving group (2,6-dimethylphenol) formed in a hydrogenolytic step 




The absolute configuration of a representative example (3r) of our Michael adducts was supported by quantum 
chemical calculations using the Gaussian 09 package.21 Conformation analysis was carried out for the molecule 
using the Austin model 1 (AM1) method.22 The five lowest energy conformers, which lie at maximum 6 kJ/mol 
above the most stable one, were considered in the subsequent calculations. The geometries for all of these 
conformers were further optimized at the density functional theory (DFT) level choosing the PBE0 
functional23,24and the 6-311++G** basis set. The optimized geometry for the most stable conformer is presented 
in Fig. 2. Vertical excitation energies as well as oscillator and rotator strengths (in the velocity gauge) were 
calculated for the conformers using the time-dependent DFT method25 with the same functional and basis set. 
The theoretical absorption and CD curves were calculated as superpositions of individual Gaussian functions 
centered at the wavelengths of the theoretically calculated transitions and having heights proportional to the 
corresponding calculated oscillator and rotator strengths, respectively. The spectra of the individual conformers 
were Boltzmann-weighted. The simulated spectra were normalized so that the height of the most intense band 
should be identical to that of the experimental spectra. Further the spectra were shifted by 20 nm towards red 
so that the position of the most intense band of the absorption spectra should be identical (Figure 3). The 
agreement of the experimental and theoretical absorption spectra of the compound is satisfactory and justifies 
the selection of the applied theoretical model. The signs of the dominant features in the measured and 
computed CD spectra are identical, thus the absolute configuration of the synthesized compound is identical to 
that for the isomers considered in the calculations. Consequently, we can conclude that the absolute 
configuration of the obtained stereoisomer is S (Figure 2). 
It is expected that the absolute configuration for the remaining examples can be assigned by analogy to be the 
same with all catalysts, except for 4d and 4e. These catalysts generated the opposite enantiomer (see Table 1, 




In summary, benzyl substituted cinchona based squaramide were used the first time to catalyse  a highly 
enantioselective Michael addition of α-nitroethylphosphonates to acrylic acid aryl esters. By comparing the 
experimental and quantum chemically calculated CD spectra the absolute configuration of one of the adducts 
(3r) could be deduced to be S. The cyclic quaternary aminophosphonate (5) has been obtained by catalytic 






  5 
NMR spectra were recorded on Bruker Avance-DRX-500 and 300 instruments using tetramethylsilane (1H, 13C) as 
internal standard and 85% H3PO4 (
31P) as external standard, in CDCl3 solution, except as otherwise stated. Low 
resolution MS measurements were carried out on an AB Sciex API2000 tandem mass spectrometer coupled with 
a Perkin Elmer Series 200 LC system. Samples were measured either in electrospray (ESI) or in atmospheeric 
pressure chemical ionization (APCI) mode. Source conditions were: spray voltage (ESI): 5000 V, needle current 
(APCI): 4 A, drying temperature (ESI): 300 °C, vaporizer temperature (APCI): 300 °C, nebulizing gas: 40 psi, 
drying gas: 40 psi, declustering potential: 30 V, scan range: 50-Da, scan time: 1 sec. All parameters were 
controlled and the data were processed by Analyst 1.5 software. High-resolution MS measurements were 
carried out on a Waters Q-TOF Premier mass spectrometer operated in ESI positive ionization mode. The HPLC 
measurements were carried out on a Jasco PU 1580 apparatus equipped with a Jasco UV1575 detector. Optical 
rotations were measured with Perkin Elmer 241 polarimeter at room temperature. Circular dichroism spectra 
were taken on a Jasco J-810 spectropolarimeter. 
4.2. Synthesis of α-nitroethylphosphonates 1 
The procedure described in ref. 17 was followed. 
4.2.1. (1-Nitroethyl)-phosphonic acid diethyl ester (1a)17b Purification by distillation, bp: 82–92 °C/0.2 mmHg. 
Pale yellow oil. Yield: 68%. 1H NMR (500 MHz): δ 1.38 (t, J = 6.8 Hz, 3H), 1.39 (t, J = 6.9 Hz, 3H), 1.82 (dd, JHP = 
16.2 Hz, JHH = 7.2 Hz, 3H), 4.10–4.35 (m, 4H), 4.95–5.06 (m, 1H). 
13C NMR (75.5 MHz) δ 14.51 (d, JHP = 3.7 Hz CH3), 
16.30 (d, JHP = 3.9 Hz, CH3), 16.38 (d, JHP = 3.6 Hz, CH3), 64.25 (d, JPC = 6.4 Hz, OCH2), 64.42 (d, JPC = 6.9 Hz, OCH2), 
79.51 (d, JHP = 144.5 Hz, PCH). 
31P NMR (121.5 MHz) δ 13.62. 
4.2.2. (1-Nitroethyl)-phosphonic acid diisopropyl ester (1b)17a Purification by distillation, bp: 88–95 °C/0.2 
mmHg. Pale yellow oil. Yield: 63%. 1H NMR (500 MHz) δ 1.64 (m, 12H), 1.79 (dd, JHP = 16.1 Hz, JHH = 7.1 Hz, 3H), 
4.71–4.85 (m, 2H), 4.86–5.05 (m, 1H). 13C NMR (75.5 MHz) δ 14.74 (d, JHP = 3.8 Hz, CH3), 23.78 (d, JHP = 5.4 Hz, 
CH3), 23.83 (d, JHP = 5.3 Hz, CH3), 24.15 (d, JHP = 5.2 Hz, CH3), 24.22 (d, JHP = 5.0 Hz, CH3), 73.53 (d, JHP = 2.5 Hz, 
CH), 73.62, (d, JHP = 2.9 Hz, CH) 80.2 (d, JHP = 145.1 Hz, PCH). 
31P NMR (121.5 MHz) δ 11.5. 
4.2.3. (1-Nitroethyl)-phosphonic acid dibutyl ester (1c) Purification by column chromatography (eluent: ethyl 
acetate–hexane = 7:3) Oil. Yield: 71%. 1H NMR (500 MHz) δ 0.88 (t, J = 7.3 Hz, 3H), 1.23–1.40 (m, 2H), 1.53–1.65 
(m, 2H), 1.74 (dd, JHP = 16.2 Hz, JHH = 7.2 Hz, 3H), 4.06–4.16 (m, 2H), 4.85–5.03 (m, 1H). 
13C NMR (75.5 MHz) δ 
13.75 (CH3), 14.71 (d, JPC = 3.8 Hz, CH3), 18.80 (d, JPC = 2.2 Hz, CH2), 32.56 (d, JPC = 4.0 Hz, CH2), 32.64 (d, JPC = 3.9 
Hz, CH2), 68.09 (d, JPC = 6.9 Hz, OCH2), 68.22 (d, JPC = 7.2 Hz, OCH2), 79.59 (d, JPC = 144.3 Hz, PCH). 
31P NMR (121.5 
MHz) 13.5. MS (APCI) M/z (rel intensity) 268.3 ([MH+], 48), 212.0 (52), 156.0 (100), 110.1 (34).  
4.3. Synthesis of aryl acrylates 2 
The procedure discribed in ref. 18 was followed. The crude products were purified by column chromatography 
(eluent: hexane–ethyl acetate = 8:2). 
4.3.1. Acrylic acid phenyl ester (2a)18 Oil. Yield: 78%. 1H NMR (300 MHz) δ 6.01 (d, J = 10.4 Hz, 1H), 6.32 (dd, J = 
17.3, 10.4 Hz, 1H), 6.60 (d, J = 17.3 Hz, 1H), 7.18 (d, J = 7.6 Hz, 2HAr), 7.24 (t, J = 8.3 Hz, 1HAr), 7.34 (dd, J = 8.3, 7.6 
Hz, 2HAr). 
13C NMR (75.5 MHz) δ 121.75 (Ar), 126.09 (Ar), 128.20 (CH2=CH), 129.66 (Ar), 132.73 (CH2=CH), 150.82 
(Arq), 164.77 (CO). 
4.3.2. Acrylic acid 4-chlorophenyl ester (2b) Oil. Yield: 85%. 1H NMR (300 MHz) δ 6.02 (d, J = 11.6 Hz, 1H), 6.30 
(dd, J = 17.3, 11.6 Hz, 1H), 6.60 (d, J = 17.3 Hz, 1H), 7.08 (d, J = 8.8 Hz, 2H), 7.35 (d, J = 8.8 Hz, 2H). 13C NMR (75.5 
MHz) δ 122.87 (Ar), 126.45 (CH2=CH), 130.90 (Arq), 131.81 (Ar), 133.10 (CH2=CH), 149.64 (Arq), 161.25 (CO). 
4.3.3. Acrylic acid 4-nitrophenyl ester (2c) Oil. Yield: 83%. 1H NMR (300 MHz) δ 6.13 (d, J = 10.5 Hz, 1H), 6.36 
(dd, J = 17.4, 10.5 Hz, 1H), 6.65 (d, J = 17.4 Hz, 1H), 8.21 (d, J = 9.0 Hz, 2H), 8.29 (d, J = 9.0 Hz, 2H). 13C NMR (75.5 
MHz) δ 120.42 (Ar), 126.87 (CH2=CH), 127.11 (Ar), 132.38 (CH2=CH), 143.65, (Arq), 158.64 (Arq), 161.35 (CO). 
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4.3.4. Acrylic acid 3-nitrophenyl ester (2d) Oil. Yield: 77%. 1H NMR (300 MHz): δ 6.17 (d, J = 10.4 Hz, 1H), 6.37 
(dd, J = 17.3, 10.4 Hz, 1H), 6.66 (d, J = 17.3 Hz, 1H), 7.31–7.65 (m, 2H), 7.95–8.16 (m, 2H). 13C NMR (75.5 MHz) δ 
117.71 (Ar), 120.81 (Ar), 127.15 (CH2=CH), 127.52 (Ar), 131.75  (Ar), 132.91 (CH2=CH), 149.12 (Arq), 151.72 (Arq), 
161.45 (CO). 
4.3.5. Acrylic acid 2-nitrophenyl ester (2e) Oil. Yield: 78%. 1H NMR (300 MHz): δ 6.12 (d, J = 10.5 Hz, 1H), 6.37 
(dd, J = 17.3, 10.5 Hz, 1H), 6.67 (d, J = 17.3 Hz, 1H), 7.30 (d, J = 8.1 Hz, 1H), 7.40–7.44 (m, 1H), 7.66–7.69 (m, 1H), 
8.11 (d, J = 8.2 Hz, 1H). 13C NMR (75.5 MHz) δ 122.42 (Ar), 125.22 (Ar), 126.87 (CH2=CH), 127.52 (Ar), 132.38 
(CH2=CH), 133.67 (Ar), 138.20 (Arq), 146.75 (Arq), 162.88 (CO). 
4.3.6. Acrylic acid p-tolyl ester (2f) Oil. Yield: 70%. 1H NMR (300 MHz) δ 2.39 (s, 3H), 6.02 (d, J =10.4 Hz, 1H), 
6.38 (dd, J = 17.2, 10.4 Hz, 1H), 6.62 (d, J = 17.2 Hz, 1H), 7.05 (d, J = 8.3 Hz, 2HAr), 7.22 (d, J = 8.3 Hz, 2HAr). 
13C 
NMR (75.5 MHz) δ 21.05 (CH3), 121.37 (Ar), 128.22 (CH2=CH), 130.12 (Ar), 132.49 (CH2=CH), 135.67 (Arq), 148.34 
(Arq), 164.92 (CO). 
4.3.7. Acrylic acid m-tolyl ester (2g) Oil. Yield: 75%. 1H NMR (300 MHz) δ 2.39 (s, 3H), 6.02 (d, J =10.4 Hz, 1H), 
6.34 (dd, J = 17.4, 10.4 Hz, 1H), 6.62 (d, J = 17.4 Hz, 1H), 6.93–7.02 (m, 2HAr), 7.07 (d, J = 7.07 Hz, 1HAr), 7.29 (m, 
1HAr). 
13C NMR (75.5 MHz) δ 21.38 (CH3), 118.51 (Ar), 122.16 (Ar), 126.32 (Ar), 128.09 (CH2=CH), 129.20 (Ar), 
132.44 (CH2=CH), 139.69 (Arq), 150.59 (Arq), 164.72 (CO). 
4.3.8. Acrylic acid o-tolyl ester (2h) Oil. Yield: 77%. 1H NMR (300 MHz) δ 2.35 (s, 3H), 6.03 (d, J = 10.5 Hz, 1H), 
6.37 (dd, J = 17.3, 10.5 Hz, 1H), 6.62 (d, J = 17.3 Hz, 1H), 7.02–7.04(m, 2HAr), 7.12–7.16 (m, 1HAr), 7.18–7.19 (m, 
1HAr). 
13C NMR (75.5 MHz) δ 16.31 (CH3), 119.03 (Ar), 125.74 (Ar), 126.71 (Ar), 127.18 (CH2=CH), 128.32 (Ar), 
129.78 (Arq),  133.26 (CH2=CH), 152.74 (Arq), 164.67 (CO). 
4.3.9. Acrylic acid 2,6-dimethylphenyl ester (2i) Oil. Yield: 74%. 1H NMR (300 MHz) δ 2.15 (s, 6H), 6.01 (d, J = 
10.4 Hz, 1H), 6.37 (dd, J = 17.3, 10.4 Hz, 1H), 6.64 (d, J = 17.3 Hz, 1H), 7.06 (s, 3HAr). 
13C NMR (75.5 MHz) δ 16.51 
(CH3), 126.12 (CH2=CH), 127.79 (Ar), 128.79 (Ar), 130.42 (Ar), 132.71 (CH2=CH), 148.22 (Arq), 164.03 (CO). 
4.3.10. Acrylic acid 4-tert-butylphenyl ester (2j) Oil. Yield: 81%. 1H NMR (300 MHz) δ 1.32 (s, 9H), 5.99 (d, J = 
10.4 Hz, 1H), 6.32 (dd, J = 17.3, 10.4 Hz, 1H), 6.59 (d, J= 17.3 Hz, 1H), 7.05 (d, J = 8.6 Hz, 2HAr), (d, J = 8.6 Hz, 2HAr). 
13C NMR (75.5 MHz) δ 31.64 (CH3q), 34.70 (Cq), 121.02 (Ar), 126.54 (CH2=CH), 128.29 (Ar), 132.53 (CH2=CH), 
148.44 (Arq), 148.87 (Arq), 164.93 (CO). 
4.3.11. Acrylic acid 4-tert-butyl-2-methylphenyl ester (2k) Oil. Yield: 68%. 1H NMR (300 MHz) δ 1.38 (s, 9H), 2.25 
(s, 3H), 6.03 (d, J = 10.4 Hz, 1H), 6.39 (dd, J = 17.3, 10.4 Hz, 1H), 6.66 (d, J = 17.3 Hz, 1H), 7.04 (d, J = 8.2 Hz, 1H), 
(d, J = 9.6 Hz, 2H). 13C NMR (75.5 MHz) δ 16.65 (CH3), 31.64 (CH3q), 34.70 (Cq), 121.32 (Ar), 124.10 (Ar), 128.15 
(CH2=CH), 128.37 (Ar), 129.38 (Arq), 132.51 (CH2=CH), 147.06 (Arq), 149.02 (Arq), 164.69 (CO). 
4.3.12. Acrylic acid naphtalen-2-yl ester (2l) Oil. Yield: 78%. 1H NMR (300 MHz) δ 6.04 (d, J = 10.4 Hz, 1H), 6.37 
(dd, J = 17.2, 10.4 Hz, 1H), 6.65 (d, J = 17.2 Hz, 1H), 7.27 (dd, J = 8.9 Hz, 2.1 Hz, 1HAr), 7.41-7.54 (m, 2HAr), 7.61 (d, 
J = 1.4 Hz, 1H), 7.76- 7.81 (m, 3HAr). 
13C NMR (75.5 MHz) δ 118.58 (Ar), 126.64 (Ar), 127.74 (CH2=CH), 127.84 (Ar), 
128.04 (Ar), 129.48 (Ar), 131.56 (Arq), 132.72 (CH2=CH), 133.83 (Arq), 148.31 (Arq), 164.77 (CO). 
4.3.13. Acrylic acid 4-methoxyphenyl ester (2m) Oil. Yield: 81%. 1H NMR (300 MHz, CDCl3) δ 3.81 (s, 3H), 6.02 (d, 
J = 10.4 Hz, 1H), 6.32 (dd, J = 17.4, 10.4 Hz, 1H), 6.61 (d, J = 17.4 Hz, 1H), 6.92 (d, J = 9.0 Hz, 2H), 7.06 (d, J = 9.0 
Hz, 2H). 13C NMR (75.5 MHz) δ 55.54 (CH3), 116.51 (Ar), 122.95 (Ar), 127.18 (CH2=CH), 133.21 (CH2=CH), 147.78 
(Arq), 158.72 (Arq), 162.58 (CO). 
4.3.14. Acrylic acid 3-methoxyphenyl ester (2n) Oil. Yield: 77%. 1H NMR (300 MHz) δ 3.81 (s, 3H), 6.02 (d, J = 
10.4 Hz, 1H), 6.34 (dd, J = 17.3, 10.4 Hz, 1H), 6.63 (d, J = 17.3 Hz, 1H), 6.66 (t, J = 2.2 Hz, 1HAr), 6.77 (dd, J = 8.2 
Hz, 2.2 Hz, 1H) 6.82 (dd, J = 8.2 Hz, 2.1 Hz, 1H), 7.31 (t, J = 8.2 Hz, 1H). 13C NMR (75.5 MHz) δ 55.65 (CH3), 107.75 
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(Ar), 112.03 (Ar), 113.95 (Ar), 128.18 (CH2=CH), 130.05 (Ar), 132.76 (CH2=CH), 151.78 (Arq), 160.74 (Arq), 164.67 
(CO). 
4.3.15. Acrylic acid 2-methoxyphenyl ester (2o) Oil. Yield: 77%. 1H NMR (300 MHz) δ 3.77 (s, 3H), 5.95 (d, J = 
10.5 Hz, 1H), 6.33 (dd, J = 17.3, 10.5 Hz, 1H), 6.68 (d, J = 17.3 Hz, 1H), 7.04–7.06 (m, 2H), 7.16–7.17 (m, 1H), 
7.18–7.19 (m, 1H). 13C NMR (75.5 MHz) δ 55.84 (CH3), 119.75 (Ar), 125.55 (Ar),  125.74 (Ar), 126.61 (Ar), 127.18 
(CH2=CH), 133.26 (CH2=CH), 148.78 (Arq), 152.74 (Arq), 162.67 (CO). 
4.3.16. Acrylic acid 3,5-dimethoxyphenyl ester (2p) Oil. Yield: 81%. 1H NMR (300 MHz) δ 3.79 (s, 6H), 6.03 (d, J = 
10.4 Hz, 1H), 6.32 (dd, J = 17.3, 10.4 Hz, 1H), 6.33 (d, J = 2.1 Hz, 2HAr), 6.38 (d, J = 2.1 Hz, 1HAr), 6.62 (d, J = 17.3 
Hz, 1H). 13C NMR (75.5 MHz) δ 55.73 (CH3), 98.63 (Ar), 100.37 (Ar), 128.15 (CH2=CH), 132.81 (CH2=CH), 152.35 
(Arq), 161.38 (Arq), 164.59 (CO). 
4.3.17. Acrylic acid 2,6-dimethoxyphenyl ester (2r) Oil. Yield: 70%. 1H NMR (300 MHz) δ 3.81 (s, 6H), 6.01 (d, J = 
10.4 Hz, 1H), 6.35 (dd, J = 17.3, 10.4 Hz, 1H), 6.62 (d, J = 8.4 Hz, 2HAr), 6.63 (d, J = 17.3 Hz, 1H), 7.14 (t, J = 8.4 Hz, 
1HAr). 
13C NMR (75.5 MHz) δ 56.36 (CH3), 105.12 (Ar), 126.51 (Ar), 127.68 (CH2=CH), 128.76 (Arq), 132.63 
(CH2=CH), 152.58 (Arq), 164.04 (CO). 
4.3.18. 4-Acryloyloxy benzoic acid methyl ester (2s) Pale yellow solid. mp: 69–72°C. Yield: 58%. 1H NMR (300 
MHz) δ 3.92 (s, 3H), 6.06 (d, J = 10.4 Hz, 1H), 6.32 (dd, J = 17.3, 10.5 Hz, 1H), 6.63 (d, J = 17.3 Hz, 1H), 7.23 (d, J = 
8.5 Hz, 2HAr), 8.09 (d, J = 8.5 Hz, 2HAr). 
13C NMR (75.5 MHz) δ 50.85 (CH3), 121.51 (Ar), 127.22 (CH2=CH), 128.13 
(Arq), 133.69 (CH2=CH), 133.91 (Ar), 155.78 (Arq), 162.58 (CO), 165.33 (CO). 
4.3.19. Acrylic acid benzo[1,3]dioxolyl ester (2t) Oil. Yield: 80%. 1H NMR (300 MHz) δ 5.97 (s, 2H), 5.99 (dd, J = 
10.4 Hz, 1.2 Hz, 1H), 6.28 (dd, J = 17.3, 10.4 Hz, 1H), 6.57 (dd, J = 8.4 Hz, 2.3 Hz, 1HAr), 6.58 (dd, J = 17.2 Hz, 1.3 
Hz, 1H), 6.65 (d, J = 2.3 Hz 1HAr), 6.78 (d, J= 8.4 Hz, 1HAr). 
13C NMR (75.5 MHz) δ 101.76 (OCH2O), 103.58 (Ar), 
108.03 (Ar), 113.94 (Ar), 127.88 (CH2=CH), 132.61 (CH2=CH), 144.93 (Arq), 145.50 (Arq), 148.07 (Arq), 164.87 (CO). 
4.4. Typical procedure for the synthesis of 3 
To a solution of 0.25 mmol dialkyl α-nitroethyl-phosphonate 1 and 0.125 mmol catalyst 4 in toluene (4 ml) aryl 
acrylate 2 (0.3 mmol) dissolved also in toluene (2ml) was added. The reaction mixture was stirred at room 
temperature and monitored by TLC. The toluene was evaporated and the residue was purified by column 
chromatography on silica gel using ethyl acetate–hexane = 7:3 as an eluent. The catalyst was also recovered 
during column chromatography. 
4.4.1. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid phenyl ester (3a) Oil. Yield: 93%. HPLC conditions: 
Kromasil Amycoat (hexane–EtOH = 95:5, flow rate 0.3 ml/min, 220 nm, 5 °C) tminor = 91.0 min and tmajor = 102.3 
min. 1H NMR (500 MHz) δ 1.38 (t, J = 7.2 Hz, 6H), 1.85 (d, J = 14.4 Hz 3H), 2.48–2.63 (m, 1H), 2.65–2.75 (m, 2H), 
2.75–2.81 (m, 1H), 4.19–4.31 (m, 4H), 7.08 (d, J = 8.4 Hz, 2H), 7.24 (t, J = 7.7 Hz, 1H), 7.29–7.4 (m, 2H). 13C NMR 
(75.5 MHz) δ 16.54 (CH3), 16.64 (CH3), 20.29 (d, JPC = 1.6 Hz, CH3), 28.29 (d, JPC = 8.3 Hz, CH2), 30.57 (CH2), 64.68 
(d, JPC = 7.1 Hz, OCH2), 64.75 (d, JPC = 6.9 Hz, OCH2), 89.24 (d, JPC = 150.2 Hz, PC), 126.23 (Ar), 128.86 (Ar), 130.17 
(Ar), 148.20 (Arq), 169.89 (CO). 
31P NMR (121.5 MHz) δ 16.3. MS (ESI) M/z (rel intensity) 360.1 ([MH+], 100), 
266.2 (31), 238.2 (4). 
4.4.2. 4-(Diisopropyloxyphosphoryl)-4-nitropentanoic acid phenyl ester (3b) Oil. Yield: 85%. HPLC conditions: 
Kromasil Amycoat (hexane–EtOH = 95:5, flow rate 0.3 ml/min, 220 nm, 5°C) tminor = 54.3 min and tmajor = 58.7 min. 
1H NMR (500 MHz) δ 1.37 (d, J = 6.2 Hz, 6H), 1.38 (d, J = 5.9 Hz, 3H), 1.39 (d, J = 6.3 Hz, 3H), 1.84 (d, JPH = 14.4 Hz, 
3H), 2.44–2.57 (m, 1H), 2.62–2.78 (m, 2H), 2.80–2.92 (m, 1H), 4.76–4.88 (m, 2H), 7.08 (d, J = 8.4 Hz, 2H), 7.24 (t, 
J = 7.5 Hz, 1H), 7.38 (dd, J = 8.4, 5.5 Hz, 2H). 13C NMR (75.5 MHz) δ 20.09 (d, JPC = 1.7 Hz, CH3), 23.77 (d, JPC = 1.5 
Hz, CH3), 23.85 (d, JPC = 1.5 Hz, CH3), 24.39 (d, JPC = 3.5 Hz, CH3), 24.44 (d, JPC = 3.5 Hz, CH3), 29.15 (d, JPC = 3.5 Hz, 
CH2), 30.82 (CH2), 89.31 (d, JPC = 150.3 Hz, PC), 121.62 (Ar), 126.21 (Ar), 129.68 (Ar), 150.71 (Arq), 170.74 (CO). 
31P 
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NMR (121.5 MHz) δ 14.3. MS (APCI) M/z (rel intensity) 388.2 ([MH+], 51), 346.4 (27), 304.1 (34), 294.7 (7), 252.2 
(19), 210.0 (100), 122.9 (16).  
4.4.3. 4-(Dibutoxyphosphoryl)-4-nitropentanoic acid phenyl ester (3c) Oil. Yield: 82%. HPLC conditions: 
Kromasil Amycoat (hexane–EtOH = 95:5, flow rate 0.3 ml/min, 220 nm, 5°C) tminor = 21.8 min and tmajor = 24.8 min. 
1H NMR (500 MHz) δ 0.95 (t, J = 7.3 Hz, 3H), 1.37–1.45 (m, 2H), 1.62–1.73 (m, 2H), 1.86 (d, J = 14.4 Hz, 3H), 2.48–
2.64 (m, 1H), 2.62–2.81 (m, 2H), 2.81–2.94 (m, 1H), 4.11–4.25 (m, 4H), 7.08 (d, J = 7.7 Hz, 2H), 7.25 (t, J = 7.4 Hz, 
1H), 7.38–7.41 (m, 2H). 13C NMR (75.5 MHz) δ 13.60 (CH3), 13.64 (CH3), 18.70 (CH2), 20.07 (d, JPC = 1.7 Hz, CH3), 
28.95 (d, JPC = 8.3 Hz, CH2), 30.74 (CH2), 32.34 (d, JPC = 1.1 Hz, CH2), 32.50 (d, JPC = 1.1 Hz, CH2), 68.18 (d, JPC = 7.7 
Hz, OCH2), 68.28 (d, JPC = 7.7 Hz, OCH2), 89.05 (d, JPC = 150.2 Hz, PC), 121.44 (Ar), 126.06 (Ar), 129.52 (Ar), 150.51 
(Arq), 170.45 (CO). 
31P NMR (121.5 MHz) δ 16.8. MS (APCI) M/z (rel intensity) 416.2 ([MH+], 94), 340.2 (20), 322.3 
(93), 266.3 (85), 210.0 (100). 
4.4.4. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid 4-chlorophenyl ester (3d) Oil. Yield: 92%. HPLC conditions: 
Kromasil Cellucoat (hexane–EtOH = 9:1, flow rate 0.3 ml/min, 220 nm, 10 °C) tmajor = 36.0 min and tminor = 39.4 
min. 1H NMR (500 MHz) δ 1.38 (t, J = 7.1 Hz, 3H), 1.85 (d, J = 14.3 Hz, 3H), 2.44–2.60 (m, 1H), 2.62–2.79 (m, 2H), 
2.79–2.90 (m, 1H), 4.20–4.38 (m, 4H), 7.03 (d, J = 8.8 Hz, 2H), 7.34 (d, J = 8.8 Hz, 2H). 13C NMR (75.5 MHz) δ 
16.60 (CH3), 16.64 (CH3), 20.37 (d, JPC = 1.4 Hz, CH3), 29.11 (d, JPC = 8.2 Hz, CH2), 30.86 (CH2), 64.74 (d, JPC = 7.1 Hz, 
OCH2), 64.79 (d, JPC = 7.1 Hz, OCH2), 89.11 (d, JPC = 150.5 Hz, PC), 123.0 (Ar), 129.76 (Ar), 131.63 (Arq), 149.14 
(Arq), 170.44 (CO). 
31P NMR (121.5 MHz) δ 16.2. MS (APCI) M/z (rel intensity) 394.4 ([MH+], 44), 266.3 (100), 
238.2 (57), 210.2 (56), 163.1 (10), 123.1 (11). 
4.4.5. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid 4-nitrophenyl ester (3e) Oil. Yield: 92%. HPLC conditions: 
Kromasil Cellucoat (hexane–EtOH = 9:1, flow rate 0.5 ml/min, 256 nm, 10 °C) tmajor = 54.2 min and tminor = 63.4 
min 1H NMR (500 MHz) δ 1.39 (t, J = 7.1 Hz, 3H), 1.87 (d, J = 14.4 Hz, 3H), 2.43–2.61 (m, 1H), 2.79–2.90 (m, 3H), 
4.20–4.38 (m, 4H), 7.29 (d, J = 9.1 Hz, 2H), 8.28 (d, J = 9.1 Hz, 2H). 13C NMR (75.5 MHz) δ 16.40 (CH3), 16.48 (CH3), 
20.45 (d, JPC = 1.8 Hz, CH3), 29.03 (d, JPC = 7.8 Hz, CH2), 30.57 (CH2), 64.66 (d, JPC = 7.0 Hz, OCH2), 64.75 (d, JPC = 7.0 
Hz, OCH2), 88.81 (d, JPC = 151.1 Hz, PC), 122.40 (Ar), 125.31 (Ar), 145.51 (Arq), 155.13 (Arq), 169.61 (CO). 
31P NMR 
(121.5 MHz) δ 16.1. M/z (APCI) (rel intensity) 405.3 ([MH+], 48), 266.4 (100), 238.2 (73), 210.3(66), 163.2 (18), 
123.0 (21). 
4.4.6. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid 3-nitrophenyl ester (3f) Oil. Yield: 93%. HPLC conditions: 
Kromasil Cellucoat (hexane–EtOH = 9:1, flow rate 0.5 ml/min, 256 nm, 10 °C) tmajor = 46.4 min and tminor = 51.6 
min. 1H NMR (500 MHz) δ 1.39 (t, J = 7.1 Hz, 3H), 1.88 (d, J = 14.3 Hz, 3H), 2.45–2.62 (m, 1H), 2.78–2.90 (m, 3H), 
4.21–4.38 (m, 4H), 7.47 (dd, J = 8.1, 1.3 Hz, 1H), 7.58 (dd, J = 8.2, 8.1 Hz, 1H), 8.01 (s, 1H), 8.12 (dd, J = 8.2, 1.3 
Hz, 1H). 13C NMR (75.5 MHz) δ 16.56 (CH3), 16.63 (CH3), 20.60 (d, JPC = 1.8 Hz, CH3), 29.11 (d, JPC = 7.9 Hz, CH2), 
30.79 (CH2), 64.67 (d, JPC = 7.5 Hz, OCH2), 64.83 (d, JPC = 7.2 Hz, OCH2), 89.02 (d, JPC = 150.9 Hz, PC), 117.49 (Ar), 
121.17 (Ar), 128.16 (Ar), 130.34 (Ar), 148.99 (Arq), 150.91 (Arq), 170.11 (CO). 
31P NMR (121.5 MHz) δ 16.1. MS 
(APCI) M/z  (rel intensity) 405.3 ([MH+], 65), 266.0 (100), 238.0 (54), 219.9 (14), 209.9 (32), 179.3 (10), 126.1 
(11). 
4.4.7. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid 2-nitrophenyl ester (3g) Oil. Yield: 90%. HPLC conditions: 
Chiralpak AD-H (hexane–EtOH = 95:5, flow rate 0.8 ml/min, 254 nm, 10 °C) tminor = 74.9 min and tmajor = 83.6 min. 
1H NMR (500 MHz) δ 1.40 (t, J = 7.2 Hz, 3H), 1.89 (d, J = 14.4 Hz, 3H), 2.43–2.64 (m, 1H), 2.80–3.0 (m, 3H), 4.21–
4.41 (m, 4H), 7.27 (d, J = 7.9 Hz, 1H), 7.43 (dd, J = 8.3, 1.1 Hz, 1H), 7.69 (dd, J = 7.9, 1.3 Hz, 1H), 8.14 (dd, J = 8.3, 
1.3 Hz, 1H). 13C NMR (75.5 MHz) δ 16.57 (CH3), 16.64 (CH3), 20.40 (d, JPC = 1.6 Hz, CH3), 28.99 (d, JPC = 8.1 Hz, 
CH2), 30.65 (CH2), 64.71 (d, JPC = 7.2 Hz, OCH2), 64.80 (d, JPC = 7.0 Hz, OCH2), 89.13 (d, JPC = 150.5 Hz, PC), 125.40 
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(Ar), 126.15 (Ar), 127.09 (Ar), 135.16 (Ar), 141.74 (Arq), 144.13 (Arq), 169.97 (CO). 
31P NMR (121.5 MHz) δ 15.6. 
MS (ESI) M/z  (rel intensity) 405.3 ([MH+], 100), 390.4 (14), 266.3 (95), 238.0(10), 210.1(4). 
4.4.8. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid p-tolyl ester (3h) Oil. Yield: 91%. HPLC conditions: 
Kromasil Amycoat (hexane–EtOH = 95:5, flow rate 0.3 ml/min, 256 nm, 10 °C) tminor = 117.5 min and tmajor = 127.1 
min. 1H NMR (500 MHz) δ 1.38 (t, J = 7.1 Hz, 3H), 1.85 (d, J = 14.4 Hz), 2.34 (s, 3H), 2.44–2.60 (m, 1H), 2.62–2.79 
(m, 2H), 2.80–2.91 (m, 1H), 4.21–4.31 (m, 4H), 6.95 (d, J = 8.3 Hz, 2H), 7.17 (d, J = 8.3 Hz, 2H). 13C NMR (75.5 
MHz) δ 16.58 (CH3), 16.65 (CH3), 20.18 (d, JPC = 1.6 Hz, CH3), 21.08 (CH3Ar), 29.10 (d, JPC = 8.4 Hz, CH2), 30.93 (CH2), 
64.63 (d, JPC = 7.1 Hz, OCH2), 64.78 (d, JPC = 7.1 Hz, OCH2), 89.20 (d, JPC = 150.3 Hz, PC), 121.26 (Ar), 130.19 (Ar), 
135.88 (Arq), 148.46 (Arq), 170.82 (CO). 
31P NMR (121.5 MHz) δ 16.3. MS (APCI) M/z (rel intensity) 374.1 ([MH+], 
40), 266.3 (100), 238.2 (38), 210.3 (13). 
4.4.9. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid m-tolyl ester (3i) Oil. Yield: 90%. HPLC conditions: Kromasil 
Cellucoat (hexane–EtOH = 9:1, flow rate 0.3 ml/min, 256 nm, 10 °C) tmajor = 37.1 min and tminor = 40.0 min. 
1H 
NMR (500 MHz) δ 1.38 (t, J = 7.1 Hz, 3H), 1.85 (d, J = 14.6 Hz, 3H), 2.36 (s, 3H), 2.42–2.61 (m, 1H), 2.63–2.79 (m, 
2H), 2.80–2.91 (m, 1H), 4.20–4.31 (m, 4H), 6.84–6.91 (m, 2HAr), 7.04 (d, J = 7.6 Hz, 1HAr), 7.24 (d, J = 7.7 Hz, 1HAr). 
13C NMR (75.5 MHz) δ 16.40 (CH3), 16.47 (CH3), 20.02 (d, JPC = 1.7 Hz, CH3), 21.36 (CH3Ar), 28.98 (d, JPC = 8.3 Hz, 
CH2), 30.75 (CH2), 64.48 (d, JPC = 7.1 Hz, OCH2), 64.62 (d, JPC = 7.1 Hz, OCH2), 89.02 (d, JPC = 150.3 Hz, PC), 118.37 
(Ar), 122.02 (Ar), 126.88 (Ar), 129.23 (Ar), 139.75 (Arq), 150.45 (Arq), 170.57 (CO). 
31P NMR (121.5 MHz) δ 16.3. 
MS (APCI) M/z (rel intensity) 374.2 ([MH+], 79), 265.9 (100), 238.2 (74), 210.3 (38), 163.1 (14). 
4.4.10. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid o-tolyl ester (3j) Oil. Yield: 89%. HPLC conditions: 
Kromasil Cellucoat (hexane–EtOH = 9:1, flow rate 0.3 ml/min, 256 nm, 10 °C) tmajor = 35.3 min and tminor = 42.1 
min. 1H NMR (500 MHz) δ 1.38 (t, J = 7.1 Hz, 3H), 1.85 (d, J = 14.5 Hz, 3H), 2.26 (s, 3H), 2.41–2.60 (m, 1H), 2.62–
2.80 (m, 2H), 2.81–2.91 (m, 1H), 4.20–4.33 (m, 4H), 6.94–7.06 (m, 2HAr), 7.06-15 (m, 2HAr). 
13C NMR (75.5 MHz) δ 
16.46 (CH3), 16.52 (CH3), 19.13 (d, JPC = 1.7 Hz, CH3), 20.22 (CH3Ar), 28.55 (d, JPC = 8.3 Hz, CH2), 30.65 (CH2), 64.42 
(d, JPC = 7.1 Hz, OCH2), 64.58 (d, JPC = 7.1 Hz, OCH2), 89.11 (d, JPC = 150.2 Hz, PC), 119.75 (Ar), 122.84 (Ar), 126.43 
(Ar), 131.22 (Ar), 139.54 (Arq), 149.40 (Arq), 170.49 (CO). 
31P NMR (121.5 MHz) δ 16.3. MS (APCI) M/z (rel 
intensity) 374.2 ([MH+], 54), 265.9 (100), 238.0 (69), 210.3 (46), 163.1 (10). 
4.4.11. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid 2,6-dimethylphenyl ester (3k) Oil. Yield: 92%. [α]
20
D  = -
2.1 (c 1.4, CHCl3). HPLC conditions: Chiralpak AD-H (hexane–EtOH = 95:5, flow rate 0.3 ml/min, 254 nm, 10°C) 
tminor = 29.2 min and tmajor = 30.9 min. 
1H NMR (500 MHz) δ 1.40 (t, J = 7.0 Hz, 3H), 1.88 (d, J = 14.4 Hz, 3H), 2.15 
(s, 6H), 2.51–2.71 (m, 1H), 2.72–2.82 (m, 2H), 2.82–2.93 (m, 1H), 4.20–4.38 (m, 4H), 7.07 (s, 3H). 13C NMR (75.5 
MHz) δ 16.53 (CH3), 16.62 (CH3), 20.29 (d, JPC = 1.6 Hz, CH3), 23.61(CH3 Ar), 29.12 (d, JPC = 8.3 Hz, CH2), 30.85 (CH2), 
64.48 (d, JPC = 7.1 Hz, OCH2), 64.62 (d, JPC = 7.1 Hz, OCH2), 89.02 (d, JPC = 150.3 Hz, PC), 126.88 (Ar), 129.23 (Ar), 
139.75 (Arq), 148.47 (Arq), 170.32 (CO). 
31P NMR (121.5 Hz) δ (ppm) 16.3. MS (ESI) M/z (rel intensity) 388.3 
([MH+], 100), 266.3 (23), 238.3 (3). 
4.4.12. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid 4-tert-butylphenyl ester (3l) Oil. Yield: 93%. HPLC 
conditions: Kromasil Cellucoat (hexane–EtOH = 7:3, flow rate 0.1 ml/min, 256 nm, 10 °C) tmajor = 41.4 min and 
tminor = 51.2 min. 
1H NMR (500 MHz) δ 1.31 (s, 9H), 1.38 (t, J = 7.0 Hz, 3H), 1.85 (d, J = 14.4 Hz), 2.46–2.60 (m, 
1H),2.62–2.75 (m, 2H), 2.79–2.86 (m, 1H), 4.20–4.31 (m, 4H), 7.0 (d, J = 8.6 Hz, 2HAr), 7.38 (d, J = 8.6 Hz, 2HAr). 
13C 
NMR (75.5 MHz) δ 16.54 (CH3), 16.62 (CH3), 20.14 (d, JPC = 1.6 Hz, CH3), 29.10 (d, JPC = 8.4 Hz, CH2), 30.90 (CH2), 
31.60 (CCH3)3), 34.69 (CCH3)3), 64.62 (d, JPC = 7.2 Hz, OCH2), 64.76 (d, JPC = 7.1 Hz, OCH2), 89.20 (d, JPC = 150.2 Hz, 
PC), 120.88 (Ar), 126.56 (Ar), 148.31 (Arq), 149.04 (Arq), 170.78 (CO). 
31P NMR (121.5 MHz) δ 16.3. MS (APCI) M/z 
(rel intensity) 416.1 ([MH+], 69), 266.2 (100), 238.3 (8.5), 210.3 (18). 
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13. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid 4-tert-butyl-2-methylphenyl ester (3m) Oil. Yield: 93%. [α]
20
D  
= -0.63 (c 1.75, CHCl3). HPLC conditions: Chiralpak AD-H (hexane–EtOH = 95:5, flow rate 0.3 ml/min, 254 nm, 10 
°C) tminor = 37.9 min and tmajor = 47.1 min. 
1H NMR (500 MHz) δ 1.29 (s, 9H), 1.37 (t, J = 7.1 Hz, 6H), 1.86 (d, J = 14.3 
Hz, 3H), 2.15 (s, 3H), 2.49–2.62 (m, 1H), 2.63–2.75 (m, 2H), 2.75–2.92 (m, 1H), 4.21–4.31 (m, 4H), 6.91 (d, J = 8.1 
Hz, 1HAr), 7.18–7.21 (m, 2HAr). 
13C NMR (75.5 MHz) δ 16.51 (CH3), 16.58 (CH3Ar), 16.61 (CH3), 20.11 (d, JPC = 1.3 Hz, 
CH3), 28.83 (d, JPC = 8.4 Hz, CH2), 30.93 (CH2), 31.58 (CH3q), 34.54 (Cq), 64.59 (d, JPC = 7.5 Hz, OCH2), 64.98 (d, JPC = 
7.5 Hz, OCH2), 89.20 (d, JPC = 150.2 Hz, PC), 121.15 (Ar), 124.07 (Ar), 128.34 (Ar), 129.09 (Arq), 146.95 (Arq), 
149.10 (Arq), 170.47 (CO). 
31P NMR (121.5 MHz) δ 16.3. MS (ESI) M/z (rel intensity) 430.3 ([MH+], 100), 266.2 (7). 
4.4.14. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid naphthalen-2-yl ester (3n) Oil. Yield: 89%. HPLC 
conditions: Kromasil Cellucoat (hexane–EtOH = 9:1, flow rate 0.8 ml/min, 256 nm, 10 °C) tmajor = 33.1 min and 
tminor = 53.1 min. 
1H NMR (500 MHz) δ 1.39 (t, J = 7.1 Hz, 6H), 1.88 (d, J = 14.6 Hz 3H), 2.54–2.64 (m, 1H), 2.72–
2.81 (m, 2H), 2.81–2.91 (m, 1H), 4.19–4.31 (m, 4H), 7.22 (dd, J = 8.9, 2.2 Hz, 1HAr), 7.48 (t, J = 7.7 Hz, 2HAr), 7.56 
(d, 2Hz, 1HAr), 7.79 (d, J = 2.0 Hz, 1HAr), 7.82–7.91 (m, 2HAr). 
13C NMR (75.5 MHz) δ 16.55 (CH3), 16.64 (CH3), 20.28 
(d, JPC = 1.6 Hz, CH3), 29.19 (d, JPC = 8.3 Hz, CH2), 30.95 (CH2), 64.71 (d, JPC = 7.2 Hz, OCH2), 64.83 (d, JPC = 7.2 Hz, 
OCH2), 89.21 (d, JPC = 150.5 Hz, PC), 118.6 (Ar), 121.07 (Ar), 126.03 (Ar), 126.86 (Ar), 127.88 (Ar), 127.98 (Ar), 
129.71 (Ar), 131.73 (Arq), 133.92 (Arq), 148.31 (Arq), 170.81 (CO). 
31P NMR (121.5 MHz) δ 16.3. MS (APCI) M/z  
(rel intensity) 410.2 ([MH+], 100), 265.9 (66), 238.2 (55), 220.2 (21), 210.3 (65), 179.3 (19), 123.1 (19). 
4.4.15. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid 4-methoxyphenyl ester (3o) Oil. Yield: 93%. HPLC 
conditions: Kromasil Cellucoat (hexane–EtOH = 9:1, flow rate 0.3 ml/min, 256 nm, 10 °C) tmajor = 50.7 min and 
tminor = 58.2 min. 
1H NMR (500 MHz) δ 1.39 (t, J = 7.0 Hz, 6H), 1.87 (d, J = 14.4 Hz, 3H), 2.44–2.62 (m, 1H),2.62–
2.78 (m, 2H), 2.79–2.93 (m, 1H), 3.81 (s, 3H), 4.19–4.38 (m, 4H), 6.90 (d, J = 9.0 Hz, 2HAr), 7.01 (d, J = 9.0 Hz, 
2HAr). 
13C NMR (75.5 MHz) δ 16.58 (CH3), 16.65 (CH3), 20.20 (d, JPC = 1.5 Hz, CH3), 29.11 (d, JPC = 8.4 Hz, CH2), 
30.94 (CH2), 55.82 (OCH3), 64.63 (d, JPC = 7.2 Hz, OCH2), 64.77 (d, JPC = 7.2 Hz, OCH2), 89.20 (d, JPC = 150.3 Hz, PC), 
114.70 (Ar), 122.36 (Ar), 144.18 (Arq), 157.57 (Arq), 170.99 (CO). 
31P NMR (121.5 MHz) δ 16.3. MS (ESI) M/z (rel 
intensity) 390.2 ([MH+], 100), 266.2 (29). 
4.4.16. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid 3-methoxyphenyl ester (3p) Oil. Yield: 93%. HPLC 
conditions: Chiralpak AD-H (hexane–EtOH = 9:1, flow rate 0.5 ml/min, 254 nm, 10 °C) tminor = 58.2 min and tmajor = 
68.3 min. 1H NMR (500 MHz) δ 1.38 (t, J = 7.1 Hz, 6H), 1.86 (d, J = 14.4 Hz, 3H), 2.44–2.60 (m, 1H), 2.62–2.79 (m, 
2H), 2.81–2.92 (m, 1H), 3.80 (s, 3H), 4.19–4.38 (m, 4H), 6.64 (s, 1HAr), 6.68 (d, J = 8.2 Hz, 1HAr), 6.79 (d, J = 8.2 Hz, 
1HAr), 7.27 (t, J = 8.2 Hz, 1HAr). 
13C NMR (75.5 MHz) δ 16.56 (CH3), 16.62 (CH3), 20.20 (d, JPC = 1.6 Hz, CH3), 29.09 
(d, JPC = 8.4 Hz, CH2), 30.88 (CH2), 55.64 (OCH3), 64.69 (d, JPC = 7.2 Hz, OCH2), 64.81 (d, JPC = 6.2 Hz, OCH2), 89.15 
(d, JPC = 150.5 Hz, PC), 107.64 (Ar), 112.06 (Ar), 113.78 (Ar), 130.06 (Ar), 151.59 (Arq), 160.70 (Arq), 170.51 (CO). 
31P NMR (121.5 MHz) δ 16.3. MS (APCI) M/z (rel intensity) 390.2 ([MH+], 100), 265.9 (81), 238.0 (82), 210.3 (68), 
163.1 (16). 
4.4.17. (S)-4-(Diethoxyphosphoryl)-4-nitropentanoic acid 2-methoxyphenyl ester (3r) Oil. Yield: 93%. [α]
20
D  = -
1.0 (c 1.0, CHCl3). HPLC conditions: Kromasil Amycoat (hexane–IPA = 9:1, flow rate 0.5 ml/min, 254 nm, 10 °C) 
tminor = 91.0 min and tmajor = 102.3 min. 
1H NMR (500 MHz) δ 1.39 (t, J = 7.1 Hz, 6H), 1.87 (d, J = 14.4 Hz, 3H), 2.42–
2.63 (m, 1H), 2.63–2.81 (m, 2H), 2.81–2.98 (m, 1H), 3.83 (s, 3H), 4.20–4.41 (m, 4H), 6.96–7.06 (m, 3HAr), 7.22 (t, J 
= 8.2 Hz, 1HAr). 
13C NMR (75.5 MHz) δ 16.40 (CH3), 16.49 (CH3), 19.73 (d, JPC = 1.5 Hz, CH3), 28.53 (d, JPC = 8.7 Hz, 
CH2), 30.75 (CH2), 55.86 (OCH3), 64.41 (d, JPC = 7.2 Hz, OCH2), 64.62 (d, JPC = 7.1 Hz, OCH2), 89.17 (d, JPC = 149.9 
Hz, PC), 112.45 (Ar), 120.84 (Ar), 122.69 (Ar), 127.11 (Ar), 139.61 (Arq), 151.02 (Arq), 170.08 (CO). 
31P NMR (121.5 
MHz) δ 16.4. MS (ESI) M/z (rel intensity) 390.1 ([MH+], 100), 266.2 (58), 220.2 (48). 
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4.4.18. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid 3,5-dimethoxyphenyl ester (3s) Oil. Yield: 92%. HPLC 
conditions: Chiralpak AD-H (hexane–EtOH = 9:1, flow rate 0.8 ml/min, 214 nm, 10 °C) tminor = 74.7 min and tmajor = 
101.1 min. 1H NMR (500 MHz) δ 1.37 (t, J = 7.1 Hz, 6H), 1.84 (d, J = 14.3 Hz, 3H), 2.42-2.61 (m, 1H), 2.62–2.76 (m, 
2H), 2.76–2.94 (m, 1H), 3.76 (s, 6H), 4.17–4.37 (m, 4H), 6.25 (d, J = 2.0 Hz, 2HAr), 6.33 (t, J = 2.0 Hz, 1HAr). 
13C 
NMR (75.5 MHz) δ 16.56 (d, JPC = 1.2 Hz, CH3), 16.64 (d, JPC = 1.2 Hz, CH3), 20.23 (d, JPC = 1.6 Hz, CH3), 29.11 (d, JPC 
= 8.3 Hz, CH2), 30.89 (CH2), 55.71 (OCH3), 64.65 (d, JPC = 7.6 Hz, OCH2), 64.75 (d, JPC = 7.3 Hz, OCH2), 89.16 (d, JPC = 
150.3 Hz, PC), 98.61 (Ar), 100.25 (Ar), 152.17 (Arq), 161.36 (Arq), 170.42 (CO). 
31P NMR (121.5 Hz) δ 16.3. MS (ESI) 
M/z (rel intensity) 420.3 ([MH+], 100), 334.2 (29), 266.3 (28). 
4.4.19. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid 2,6-dimethoxyphenyl ester (3t) Oil. Yield: 92%. [α]
20
D  = 
+3.7 (c 1.5, CHCl3). HPLC conditions: Chiralpak AD-H (hexane–EtOH = 9:1, flow rate 0.8 ml/min, 214 nm, 10 °C) 
tminor = 34.4 min and tmajor = 37.9 min; 
1H NMR (500 MHz) δ 1.38 (t, J = 6.9 Hz, 6H), 1.86 (d, J = 14.5 Hz, 3H), 2.42–
2.62 (m, 1H), 2.62–2.78 (m, 2H), 2.78–2.95 (m, 1H), 3.81 (s, 6H), 4.18–4.38 (m, 4H), 6.61 (d, J = 8.4 Hz, 2HAr), 7.14 
(t, J = 8.4 Hz, 1HAr). 
13C NMR (75.5 MHz) δ 16.55 (CH3), 16.62 (CH3), 19.60 (d, JPC = 1.2 Hz, CH3), 28.47 (d, JPC = 8.3 
Hz, CH2), 30.91 (CH2), 58.30 (OCH3), 64.51 (d, JPC = 7.1 Hz, OCH2), 64.78 (d, JPC = 7.1 Hz, OCH2), 89.41 (d, JPC = 
149.7 Hz, PC), 105.03 (Ar), 126.62 (Ar), 128.76 (Arq), 152.43 (Arq), 170.02 (CO). 
31P NMR (121.5 MHz) δ (ppm) 
16.6. MS (ESI) M/z (rel intensity) 420.2 ([MH+], 100), 266.1 (55). 
4.4.20. 4-[4-(Diethoxyphosphoryl)-4-nitropentanoyloxy]-benzoic acid methyl ester (3u) Oil. Yield: 91%. HPLC 
conditions: Chiralpak AD-H (hexane–EtOH = 9:1, flow rate 0.8 ml/min, 240 nm, 10 °C) tminor = 82.1 min and tmajor = 
95.3 min. 1H NMR (500 MHz) δ 1.39 (t, J = 7.0 Hz, 6H), 1.86 (d, J = 14.3 Hz, 3H), 2.44–2.62 (m, 1H), 2.62–2.78 (m, 
2H), 2.79–2.94 (m, 1H), 3.92 (s, 3H), 4.19–4.37 (m, 4H), 7.17 (d, J = 8.7 Hz, 2HAr), 8.07 (d, J = 8.2 Hz, 2HAr). 
13C 
NMR (75.5 MHz) δ 16.40 (CH3), 16.47 (CH3), 20.25 (d, JPC = 1.6 Hz, CH3), 29.03 (d, JPC = 6.1 Hz, CH2), 30.68 (CH2), 
52.27 (OCH3), 64.54 (d, JPC = 7.1 Hz, OCH2), 64.59 (d, JPC = 7.1 Hz, OCH2), 88.93 (d, JPC = 150.5 Hz, PC), 121.50 (Ar), 
127.97 (Ar), 131.25 (Arq), 154.08 (Arq), 166.27 (CO), 169.96 (CO). 
31P NMR (121.5 MHz) δ 16.1. MS (ESI) M/z (rel 
intensity) 418.2 ([MH+], 100), 266.2 (23). 
4.4.21. 4-(Diethoxyphosphoryl)-4-nitropentanoic acid benzo[1,3]dioxolyl ester (3v) Oil. Yield: 90%. HPLC 
conditions: Chiralpak AD-H (hexane–EtOH = 9:1, flow rate 0.8 ml/min, 254 nm, 10 °C) tminor = 77.1 min and tmajor = 
89.5 min. 1H NMR (500 MHz) δ 1.39 (t, J = 7.1 Hz, 6H), 1.86 (d, J = 14.4 Hz, 3H), 2.42–2.59 (m, 1H), 2.60–2.66 (m, 
2H), 2.76–2.91 (m, 1H), 4.19–4.38 (m, 4H), 5.99 (s, 2H), 6.53 (dd, J = 8.4, 2.3 Hz, 1HAr), 6.56 (d, J = 2.3 Hz, 1HAr), 
6.77 (d, J = 8.4 Hz, 1HAr). 
13C NMR (75.5 MHz) δ 16.45 (d JPC = 1.3 Hz, CH3), 16.52 (d, JPC = 1.1 Hz, CH3), 20.09 (d, JPC 
= 1.6 Hz, CH3), 28.88 (d, JPC = 8.4 Hz, CH2), 30.77 (CH2), 64.50 (d, JPC = 7.2 Hz, OCH2), 64.66 (d, JPC =7.2 Hz, OCH2), 
89.07 (d, JPC = 150.3 Hz, PC), 101.87 (OCH2O), 103.65 (Ar), 108.06 (Ar), 113.87 (Ar), 144.86 (Arq), 145.58 (Arq), 
148.13 (Arq), 170.81 (CO). 
31P NMR (121.5 Hz) δ 16.3. MS (ESI) M/z (rel intensity) 404.1 ([MH+], 100), 266.3 (25). 
4.5. Synthesis of catalysts 4l-4m 
Procedure described in ref 19 was followed starting from the corresponding alkaloid amine. 
4.5.1. 3-((3,5-Bis(trifluoromethyl)benzyl)amino)-4-(((1S)-(6-methoxyquinolin-4-yl)((2S,4S,5R)-5-
vinylquinuclidin-2-yl)methyl)amino)cyclobut-3-ene-1,2-dione (4l) White solid. H1NMR (300 MHz, CDCl3:CD3OD 
1:1) δ 0.62-0.77 (m, 1H), 1.46-1.76 (m, 5H), 2.32-2.47 (m, 1H), 2.67-2.90 (m, 2H), 3.32-3.62 (m, 2H), 4.00 (s, 3H), 
4.80 (d, J = 15 Hz, 1H), 4.93 (d, J = 15 Hz, 1H), 5.01 (s, 1H), 5.06 (d, J = 8 Hz, 1H), 5.82 (ddd, J = 2, 8, 17 Hz, 1H), 
6.23(d, J = 10 Hz, 1H), 7.35-7.46 (m, 2H), 7.74-7.85 (m, 5H), 7.94 (d, J = 10 Hz, 1H), 8.66 (d, J = 4 Hz, 1H). C13NMR 
(75 MHz) δ 182.543, 182.398, 167.436, 167.418, 167.054, 159.042, 146.660, 144.063, 140.772, 132.113, 
131.670, 130.435, 128.011, 127.869, 127.830, 124.821, 123.382, 123.363, 121.455, 121.406, 121.355, 121.209, 
114.731, 114.696, 114.671, 114.633, 100.770, 59.752, 55.779, 55.600, 46.657, 40.650, 38.733, 38.707, 38.678, 
27.056, 26.942, 25.988. HRMS calculated for C33H30F6N4O3 (MH
+): 645.2295 found: 645.2296. 
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4.5.2 3-(Benzylamino)-4-(((1S)-((2S,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-
yl)methyl)amino)cyclobut-3-ene-1,2-dione (4m) White solid. H1NMR (300 MHz, CDCl3:CD3OD 1:1) δ 0.54-0.72 
(m, 1H), 0.83 (t, J = 7 Hz, 3H), 1.16-1.74 (m, 7H), 2.35-2.51 (m, 1H), 2.61-2.81 (m, 1H), 3.16-3.40 (m, 2H), 3.41-
3.61 (m, 1H), 3.99 (s, 3H), 4.55 (bs, 2H), 4.69 (q, J = 15 Hz, 2H), 6.22 (d, J = 10 Hz, 1H), 7.10-7.30 (m, 5H), 7.38 (bs, 
1H), 7.40 (dd, J = 12, 2 Hz, 1H), 7.83 (bs, 1H), 7.93 (d, J = 9 Hz, 1H), 8.64 (d, J = 4 Hz, 1H). C13NMR (75MHz) δ 
182.457, 182.057, 167.586, 166.820, 159.017, 146.707, 144.658, 144.084, 137.583, 130.430, 128.629, 128.105, 
127.707, 127.482, 123.354, 100.980, 59.672, 57.487, 55.832, 47.890, 40.705, 36.622, 27.739, 27.172, 25.888, 
24.932, 11.490, HRMS calculated for C31H34N4O3 (MH
+): 511.2704 found: 511.2705. 
4.5.3. 3-(Benzylamino)-4-(((1S)-((2S,4S,5S)-5-ethynylquinuclidin-2-yl)(6-methoxyquinolin-4-
yl)methyl)amino)cyclobut-3-ene-1,2-dione (4n) White solid. H1NMR (300 MHz, CDCl3:CD3OD 1:1) δ 0.57-0.86 
(m, 1H), 1.05-1.34 (m, 4H), 1.41-1.69(m, 2H), 1.70-1.88(m, 2H), 2.07-2.18(m,. 4H), 2.47-2.80(m, 2H), 2.87-3.10 
(m, 1H), 3.26-3.42 (m, 1H), 3.42-3.70 (m, 2H), 3.94 (s, 3H), 4.53-4.76 (m, 2H), 7.07-7.27 (m, 5H), 7.28-7.50 (m, 
4H), 7.74 (bs, 1H), 7.90 (d, J=9 Hz, 1H), 8.62 (d, J = 4 Hz, 1H). C13NMR (75.5 MHz) δ 181.060, 165.536, 165.516, 
157.920, 142.989, 136.367, 129.414, 127.497, 126.917, 126.890, 126.579, 126.510, 126.441, 126.382, 122.274, 
122.250, 122.230, 99.786, 99.667, 58.197, 55.578, 54.779, 39.134, 28.373, 28.358, 25.693, 25.296, 25.097, 
23.983. HRMS calculated for C31H30N4O3 (MH
+): 507,2391 found: 507.2396. 
4.6. Typical procedure for the synthesis of (S)-(2-methyl-5-oxopyrrolidin-2-yl)-phosphonic acid diethyl ester 
(5). Over 10% Pd/C catalyst (Selcat Q, 0.53 g) Michael adduct 3 (2.5 mmol) was hydrogenated in ethanol (50 
cm3), in a 250 cm3 stainless steel autoclave equipped with a magnetic stirrer (stirring speed: 1100 rpm). The 
reduction was carried out at 30 bar and room temperature. After finishing the hydrogen uptake (4 h), the 
catalyst was filtered off and the filtrate was evaporated under vacuum. The residue was subjected to column 
chromatography on silica using CH2Cl2–EtOAc 9:1 as an eluent. By-product 6 was also isolated during column 
chromatography. Oil. Yield: 51%. [α]
20
D  = +1.0 (c 1.25, CHCl3), HPLC conditions: Chiralpak AD-H (hexane–IPA = 
95:5, flow rate 1 ml/min, 220 nm, 10 °C) tminor = 38.9 min and tmajor = 46.5 min.; 97% ee. 
1H NMR (500 MHz) δ 1.34 
(t, J = 7.1 Hz, 3H), 1.50 (d, J = 14.5 Hz, 3H), 1.87–1.94 (m, 1H), 2.34–2.42 (m, 1H), 2.48–2.62 (m, 2H), 4.09–4.22 
(m, 4H), 6.01 (s, 1NH). 13C NMR (75.5 MHz) δ 16.72 (CH3), 16.79 (CH3), 16.83 (d, JPC = 5.5 Hz, CH3), 24.02 (d, JPC = 
8.1 Hz, CH2), 30.41 (d, JPC = 7.4 Hz, CH2), 56.89 (d, JPC = 162.5 Hz, PC), 62.97 (d, JPC = 7.7 Hz, OCH2), 63.57 (d, JPC = 
7.4 Hz, OCH2), 177.48 (d, JPC = 3.5 Hz, CO). ). 
31P NMR (121.5 MHz) δ 26.6. MS (ESI) M/z (rel intensity) 236.2 
([MH+], 100). 
(2-Methyl-3,4-dihydro-2H-pyrrol-2-yl)-phosphonic acid diethyl ester (by-product 6): Oil. Yield: 39%. HPLC 
conditions: Chiralpak AD-H (hexane–IPA = 95:5, flow rate 1 ml/min, 220 nm, 20 °C) tmajor = 14.9 min and tminor = 
17.8 min.; 91% ee. 1H NMR (500 MHz) δ 1.35 (t, J = 6.9 Hz, 6H), 1.58 (d, J = 14.2 Hz, 3H), 1.80–1.91 (m, 1H), 2.31–
2.41 (m, 1H), 2.46–2.61 (m, 2H), 4.11–4.25 (m, 4H), 8.08 (d, J = 7.8 Hz, 1H). 13C NMR (75.5 MHz) δ 16.43 (CH3), 
16.51 (CH3), 16.58 (CH3), 22.69 (d, JPC = 14.3 Hz, CH2), 23.02 (d, JPC = 16.6 Hz, CH2), 35.94 (d, JPC = 4.5 Hz, CH2), 
36.33 (d, JPC = 4.5 Hz, CH2), 59.1 (d, JPC = 157.4 Hz, PC), 59.2 (d, JPC = 159.2 Hz, PC), 169.65 (d, JPC = 3.8 Hz, PC).  
31P 
NMR (121.5 MHz) δ 25.3. MS (ESI) M/z (rel intensity) 220.3 ([MH+], 100). 
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4k:  X=H,               Y=
4l:   X=3,5-diCF3,  Y=   
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ROOCR = Ph  
Scheme 1. 
 
Table 1. Michael addition of α-nitroethylphosphonate 1a to phenyl acrylate 2a in toluene, at rt, in 















1 4a 7 94 83 21 
2 4b 5 100 85 58 
3 4c 5 100 86 61 
4 4d 5 100 86 61d 
5 4e 5 100 90 62d 
6 4f 3 100 92 70 
7 4g 3 100 91 69 
8 4h 2 100 92 53 
9 4i 2 100 93 67 
10 4j 2 100 92 51 
11 4k 2 100 93 76 
12 4l 2 100 92 58 
13 4m 4 40 35 86 
  16 
14 4n 2 100 90 70 
aDetermined by 31P NMR. 
bYields of the isolated products. 
























Table 2. Dependence on solvent, temperature and catalyst loading in the Michael addition of α-














2 100 93 76 
2 CH2Cl2 14 100 79 59 
3 CH3CN 14 84 63 53 
4 THF 14 91 84 58 
5 Dioxan
e 
14 92 84 63 
6e Anisol
e 
14 100 93 55 
7 Xylene 14 97 89 57 
8d Toluen
e 
10 63 51 62 
9e Toluen
e 
10 85 77 70 
10f Toluen
e 
7 100 92 75 
11g Toluen
e 
7 84 76 70 
a-cSee Table 1. 
d-30 °C. 
e0 °C. 
fWith 5 mol% catalyst. 
gWith 2 mol% catalyst. 
 


























Table 3. Enantioselective Michael addition of nitroethyl phosphonate esters (1a-c) to aryl acrylates 
(2a-o) using 5 mol% of catalyst 4k. 
Entry R’ R Time (day)aa Yield of 3 (%)b ee (%)c 
1 Et (1a) Ph (2a) 2 93 (3a) 76 
2 iPr (1b) Ph (2a) 2 85 (3b) 64 
3 Bu (1c) Ph (2a) 2 82 (3c) 52 
4 Et (1a) 4-ClC6H4 (2b) 2 92 (3d) 68 
5 Et (1a) 4-NO2C6H4 (2c) 1 92 (3e) 64 
6 Et (1a) 3-NO2C6H4 (2d) 1 93 (3f) 67 
7 Et (1a) 2-NO2C6H4 (2e) 4 90 (3g) 40 
8 Et (1a) 4-MeC6H4 (2f) 2 91 (3h) 81 
9 Et (1a) 3-MeC6H4 (2g) 2 90 (3i) 79 
10 Et (1a) 2-MeC6H4 (2h) 2 89 (3j) 83 
11 Et (1a) 2,6-diMeC6H3 (2i) 3 92 (3k) 90 
12 Et (1a) 4-tBuC6H4 (2j) 3 93 (3l) 84 
13 Et (1a) 2-Me,4-tBuC6H3 (2k) 4 93 (3m) 89 
14 Et (1a) -Naphtyl (2l) 4 89 (3n) 60 
15 Et (1a) 4-MeOC6H4 (2m) 2 93 (3o) 80 
16 Et (1a) 3-MeOC6H4 (2n) 2 93 (3p) 79 
17 Et (1a) 2-MeOC6H4 (2o) 3 93 (3r) 85
d 
18 Et (1a) 3,5-diMeOC6H3 (2p) 3 92 (3s) 80 
19 Et (1a) 2,6-diMeOC6H3 (2r) 3 92 (3t) 96 
20 Et (1a) 4-MeO2CC6H4 (2s) 4 91(3u) 62 
21 Et (1a) 3,4-(OCH2O)C6H3 (2t) 4 90 (3v) 69 
aThe reactions were led until 100% conversion and determined by 31P NMR. 
b,cSee Table 1. 
dAbsolute configuration of 3r was derived to be S from the CD spectrum (see Section 2.3). 
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Fig. 2. Optimized geometry for the lowest-energy conformer of 4-(diethoxyphosphoryl)-4-






Figure 3. Absorption (a) and CD (b) spectra of 3r, experimental: ________ , calculated: --------- 
